RTI Surgical Offers Surgeon Education Symposium Highlighting the Future of Spine Surgery

RTI Surgical™ Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, announced today that it will host a surgeon education symposium titled Surgical Pioneers: A Debate on the Future of Spine Surgery.

The symposium will feature discussion topics such as the future of stem cells and stand-alone cervical devices versus cervical plating. John Peloza, M.D., Director of the Center for Spine Care in Dallas, TX is the course chairman for the event. This meeting is the second in a series of four educational symposia that RTI is hosting in 2014 as part of the RTI STRIDES (Surgical Training, Research, Investigation, Development, Education and Skill) surgeon education and engagement program.

“RTI’s educational symposia bring together some of the best minds in spine surgery to generate discussion, facilitate education and explore new ideas,” said Roger Rose, executive vice president, North American sales and marketing, RTI Surgical and president, RTI Donor Services. “These symposia are an element of our larger surgeon education and engagement program, in which we work with health care professionals to further best practices and benefit patients worldwide.”

About RTI Surgical Inc.

RTI Surgical is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. RTI is accredited in the U.S. by the American Association of Tissue Banks and is a member of AdvaMed. For more information, please visit www.rtix.com.

Forward Looking Statement

This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations, estimates and projections about our industry, our management's beliefs and certain assumptions made by our management. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," variations of such words and similar expressions are intended to identify such forward-looking statements. In addition, except for historical information, any statements made in this communication about anticipated financial results, growth rates, new product introductions, future operational improvements and results or regulatory actions or approvals or changes to agreements with distributors also are forward-looking statements. These statements are not guarantees of future performance and are subject to risks and uncertainties, including the risks described in public filings with the U.S. Securities and Exchange Commission (SEC). Our actual results may differ materially from the anticipated results reflected in these forward-looking statements. Copies of the company's SEC filings may be obtained by contacting the company or the SEC or by visiting RTI's website at www.rtix.com or the SEC's website at www.sec.gov.

Contacts:

RTI Surgical Inc.
Jenny Highlander, APR, 386-418-8888
Director, Corporate Communications
jhighlander@rtix.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.